BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 1975140)

  • 1. RFLP-DR beta and serological HLA-DR typing of 200 kidney recipients and 1000 controls.
    Mytilineos J; Scherer S; Hansen B; Gaweco A; Opelz G
    Transplant Proc; 1990 Aug; 22(4):1911-2. PubMed ID: 1975140
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparison of serological class II typing with DNA-DR and DNA-DQ typing of kidney donors and recipients.
    Trejaut J; Dunckley H; Sullivan JS; Doran T; Chapman J
    Transplant Proc; 1990 Oct; 22(5):2133. PubMed ID: 1977223
    [No Abstract]   [Full Text] [Related]  

  • 3. HLA-DR typing of renal allograft patients and donors by DNA-RFLP: correlation with pretransplant serotyping.
    Wood N; Joysey V; Bidwell J; Klouda P
    Transplant Proc; 1990 Oct; 22(5):2287. PubMed ID: 1977225
    [No Abstract]   [Full Text] [Related]  

  • 4. Retrospective analysis of HLA-DR typing by serology, TaqI RFLP analysis, and PCR amplification with sequence-specific primers.
    Olerup O
    Transplant Proc; 1994 Jun; 26(3):1750-1. PubMed ID: 7913273
    [No Abstract]   [Full Text] [Related]  

  • 5. Genomic HLA-DR and -DQ typing by Taq I RFLP analysis: an alternative to serologic tissue typing.
    Olerup O; Zetterquist H; Ohlson L; Carlsson B; Wallin J; Möller E
    Transplant Proc; 1990 Feb; 22(1):144. PubMed ID: 1968689
    [No Abstract]   [Full Text] [Related]  

  • 6. Nonradioactive DNA/RFLP analysis for HLA DR and DQ allotypes.
    Crosby I; Beales P; Barnes RM
    Transplant Proc; 1992 Dec; 24(6):2481-2. PubMed ID: 1361259
    [No Abstract]   [Full Text] [Related]  

  • 7. Analysis of HLA-DR matching in DNA-typed cadaver kidney transplants.
    Opelz G; Mytilineos J; Scherer S; Dunckley H; Trejaut J; Chapman J; Fischer G; Fae I; Middleton D; Savage D
    Transplantation; 1993 Apr; 55(4):782-5. PubMed ID: 7682736
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DNA heteroduplex analysis reveals mismatching of DR alleles in HLA-DR serologically matched cadaveric renal transplantation.
    Connolly J; Sinnott PJ; Ivinson AJ; Parrott NR; Martin S; Dyer PA
    Transplant Proc; 1993 Dec; 25(6):3064. PubMed ID: 7903497
    [No Abstract]   [Full Text] [Related]  

  • 9. HLA class II typing by restriction fragment length polymorphism (RFLP) in unrelated bone marrow transplant patients.
    Noreen HJ; Davidson ML; McCullough J; Bach FH; Segall M
    Transplant Proc; 1989 Feb; 21(1 Pt 3):2968-70. PubMed ID: 2468247
    [No Abstract]   [Full Text] [Related]  

  • 10. HLA-DR beta, -DQ alpha, and -DQ beta restriction fragment length polymorphisms in multiple sclerosis.
    Haegert DG; Michaud M; Schwab C; Tansey C; Décary F; Francis G
    J Neurosci Res; 1989 May; 23(1):46-54. PubMed ID: 2568496
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HLA-DR matching assessed by DNA analysis in kidney transplantation--a one-center study.
    Bignon JD; Nataf S; Hourmant M; Cesbron A; Soulillou JP; Muller JY
    Transplant Proc; 1993 Feb; 25(1 Pt 1):217-9. PubMed ID: 8094910
    [No Abstract]   [Full Text] [Related]  

  • 12. A comparison of serological, cellular and DNA-RFLP methods for HLA matching in the selection of related bone marrow donors.
    Howell WM; Evans PR; Spellerberg MB; Wilson PJ; Smith JL
    Bone Marrow Transplant; 1989 Jan; 4(1):63-8. PubMed ID: 2522330
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of HLA DR typing by polymerase chain reaction amplification with DR beta 1 sequence-specific primers on cadaveric renal allocation.
    Bryan CF; Harrell K; Aeder MI; Luger AM; Nelson PW; Pierce GE; Ross G; Shield CF; Warady BA
    Transplant Proc; 1993 Dec; 25(6):3060-3. PubMed ID: 8266452
    [No Abstract]   [Full Text] [Related]  

  • 14. Use of the HLAcDNA probe as a complementary tissue-typing test for canine kidney transplantation.
    Matsuno N; Maeda M; Uryu N; Muto M; Tamaki T; Kozaki M
    Transplantation; 1991 Jan; 51(1):282-4. PubMed ID: 1670972
    [No Abstract]   [Full Text] [Related]  

  • 15. Serology versus polymerase chain reaction-sequence-specific primers in typing for HLA-DR in Pakistani populations.
    Zafar N; Ahmed N; Saeedullah K; Naqvi A; Rizvi A
    Transplant Proc; 1996 Jun; 28(3):1270-1. PubMed ID: 8658655
    [No Abstract]   [Full Text] [Related]  

  • 16. DNA typing for related allogeneic bone marrow transplantation.
    Chiewsilp P; Sujirachato K; Mongkolsuk T; Leetrakool N; Jootar S; Chuncharunee S; Hathirat P
    Transplant Proc; 1994 Aug; 26(4):1881-2. PubMed ID: 7915053
    [No Abstract]   [Full Text] [Related]  

  • 17. About DR beta-restriction fragment length polymorphism (RFLP) analysis in kidney transplantation in connection with a paediatric patient.
    Endreffy E; Petri IB; Csajbók E; Márton J; Kaiser GI; Raskó I
    Acta Paediatr Hung; 1992; 32(2):189-97. PubMed ID: 1356380
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HLA-DR oligotyping of 100 kidney transplant patients with difficult serological typing: correlation between serology and DNA typing.
    Tiercy JM; Goumaz C; Mach B; Jeannet M
    Transplant Proc; 1991 Feb; 23(1 Pt 1):383-4. PubMed ID: 1990559
    [No Abstract]   [Full Text] [Related]  

  • 19. DNA-RFLP analysis and genotyping of HLA-DR alleles in the south of Spain.
    Martín J; Almeida D; Mialdea MJ; Rodriguez M; Mataran L; Garrido F
    Exp Clin Immunogenet; 1991; 8(2):119-20. PubMed ID: 1686399
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term kidney graft outcome based on HLA-DRB1 matching.
    Nojima M; Ichikawa Y; Ihara H; Ishibashi MO; Ohshima S; Ikoma F
    Transplant Proc; 1994 Aug; 26(4):1884-6. PubMed ID: 7915054
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.